Document ID: EPA-HQ-OPP-2005-0163-0193
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2007-10-12T04:00Z

Aldicarb Reader’s Guide

Reader’s Guide to Aldicarb E-Docket # EPA-HQ-OPP-2005-0163

EPA has created this document to provide an organizational structure to
the aldicarb e-Docket.  The docket index organizes and explains related
documents.  The first group contains the Federal Register and Docket
Organizational Documents; the second group contains the Biological and
Economics Division Documents, Environmental Fate and Effects Division
Documents, and the Health Effects Division Documents.  The Agency is
providing the “Reader’s Guide” to allow the reader to more easily
access and navigate the various items contained in the aldicarb
e-docket.

Federal Register and Docket Organizational Documents:

Docket Item 1:	Federal Register Notice: Aldicarb Interim Reregistration
Eligibility Decision; Notice of Availability

This notice announces that the risk assessments are available for public
review.

Docket Item 2:	Reader’s Guide to the Aldicarb E-Docket #
EPA-HQ-OPP-2005-0163

The reader’s guide is designed to give a brief description of all the
aldicarb documents in the aldicarb e-Docket.

Docket Item 3:	Interim Reregistration Eligibility Decision (IRED)
Document for Aldicarb.

			September 24, 2007 – Sherrie Kinard and Anne Overstreet

This document is the Interim Reregistration Eligibility Decision (IRED).

Biological and Economics Division Documents for Phase 6:

Docket Item 4:  	BEAD Response to Comments Submitted to Docket
EPA-HQ-OPP-2005-0163

			February 27, 2007 – Angel Chiri and Derek Berwald

This document is the Agency’s response to Phase 5 comments.

Docket Item 5:  	Quantitative Impact Analysis for At-peg Application of
Aldicarb to Peanuts (DP 337549)

July 11, 2007 – Angel Chiri and Derek Berwald

This document describes the alternatives and benefits associated with
the aldicarb split season use on peanut.

Docket Item 6:	Significance of Aldicarb Use in the Production of Dry
Beans, Soybeans, Pecans, Sweet Potatoes, Cotton and Citrus.

			September 20, 2007 – Derek Berwald and Angel Chiri

This document describes the significance of aldicarb use on dry beans,
soybeans, and pecans, as well as gives additional information on the
benefits associated with the use of aldicarb on pecans, sweet potatoes,
cotton, and citrus.

Environmental Fate and Effects Documents for Phase 6:

Docket Item 7:  	EFED Response to Public Comments for Aldicarb IRED:
Docket ID# Opp-2005-0163-0176			

			March 2, 2007 – Jonathan Angier, Jeannette Martinez, and Donna
Randall

This document is the Agency’s response to Phase 5 comments.

Docket Item 8:  	Aldicarb - Ecological risk results for alternative
application rate and incorporation efficiencies

		August 25, 2006 – Jonathan Angier, Jeannette Martinez, and Donna
Randall

This document calculates the risks associated with the use of aldicarb
using alternate assumptions.

Docket Item 9:  	Use of Aldicarb for Lygus Bug Suppression, Aphids, and
Mites on Alfalfa Grown for Seed Production

		August 25, 2006 – Jonathan Angier and Jeannette Martinez

This document calculates the risks associated with the use of aldicarb
on alfalfa.

Docket Item 10:  	Use of Aldicarb for Leaf Minors on Coffee, for
Nematodes on Coffee and Sugarcane, and for Aphids and Flea Beatles on
Tobacco	

			September 6, 2007 – Jonathan Angier and Jeannette Martinez

This document calculates the risks associated with the use of aldicarb
on coffee, sugarcane, and tobacco.

Docket Item 11:  	Review of “A Retrospective Groundwater Monitoring
Study for Aldicarb and Its Metabolites in the Southeastern United States
(MRID 467937-06); Mississippi Delta (MRID 467937-05); Texas (MRID
467937-04); California (MRID 467937-03); and Pacific Northwest (MRID
467937-02)

			July 24, 2007 – Nelson Thurman

This document reviews a groundwater monitoring study submitted by the
registrant.

Docket Item 12:	ADDENDUM to:  Aldicarb - Ecological risk results for
alternative application rate and incorporation efficiencies

			September 14, 2007 – Dana Spatz

This document calculates the risks associated with the use of aldicarb
using additional alternate assumptions.

Health Effects Division Documents for Phase 6:

Docket Item 13:  	Aldicarb (List A Case 0140, Chemical ID No. 098301). 
HED Response to Comments Received During the Public Comment Period.  

			February 26, 2007 – Felicia Fort, Linda Taylor, and Jeff Dawson

This document is the Agency’s response to Phase 5 comments.

Docket Item 14:  	HED Revised Human Health Risk Assessment for the
Reregistration Eligibility Decision Document (RED).  

February 26, 2007 – Felicia Fort, Linda Taylor, and Jeff Dawson

This document is the revised Human Health Risk Assessment.